Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic()

Cervical cancer is a deadly disease and the COVID-19 pandemic has the potential to further impact its lethality. Hypofractionated radiotherapy could mitigate this impact, however robust data in cervical cancer setting still is lacking. Information provided here could help institutions in reducing ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendez, Lucas C., Raziee, Hamid, Davidson, Melanie, Velker, Vikram, D'Souza, David, Barnes, Elizabeth, Leung, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255703/
https://www.ncbi.nlm.nih.gov/pubmed/32474128
http://dx.doi.org/10.1016/j.radonc.2020.05.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255703/
https://www.ncbi.nlm.nih.gov/pubmed/32474128
http://dx.doi.org/10.1016/j.radonc.2020.05.032

Ejemplares similares